BHV-1300

N/A

Report date: 2026/04/27 20:02:09

Base Information

Drug NameBHV-1300
Drug Alias NameBHV-1300
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionImmunoglobulin G degradersAsialoglycoprotein receptor binders
TargetsImmunoglobulin GAsialoglycoprotein receptor
Therapy Area/IndicationsGraves DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGraves DiseaseArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A